当前位置:首页 - 行情中心 - 重药控股(000950) - 财务分析 - 现金流量表

重药控股

(000950)

  

流通市值:94.89亿  总市值:94.89亿
流通股本:17.13亿   总股本:17.13亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金43,089,889,542.1720,196,351,385.4292,156,419,477.0465,602,358,700.9
  收到的税费返还--0-
  收到其他与经营活动有关的现金704,408,323.77413,641,514.482,439,535,741.111,387,935,328.32
  经营活动现金流入小计43,794,297,865.9420,609,992,899.994,595,955,218.1566,990,294,029.22
  购买商品、接受劳务支付的现金43,435,642,906.1121,958,766,531.9186,075,400,363.6664,046,357,537.8
  支付给职工以及为职工支付的现金971,488,272.5551,084,585.331,884,333,443.881,437,480,216.31
  支付的各项税费983,709,382.13480,353,448.31,549,825,517.881,040,794,159.32
  支付其他与经营活动有关的现金2,012,886,635.67935,963,247.784,331,725,803.352,795,927,277.19
  经营活动现金流出小计47,403,727,196.4123,926,167,813.3293,841,285,128.7769,320,559,190.62
  经营活动产生的现金流量净额-3,609,429,330.47-3,316,174,913.42754,670,089.38-2,330,265,161.4
二、投资活动产生的现金流量:
  收回投资收到的现金--339,416,960.5374,645,860.53
  取得投资收益收到的现金147,338,119.1-119,038,363.74119,038,363.74
  处置固定资产、无形资产和其他长期资产收回的现金净额189,486.8782,3081,011,324701,013
  处置子公司及其他营业单位收到的现金净额497,756.49-399,607.57399,607.57
  收到的其他与投资活动有关的现金15,506,497.5513,652,243.8858,449,051.4140,450,520.92
  投资活动现金流入小计163,531,860.0113,734,551.88518,315,307.25235,235,365.76
  购建固定资产、无形资产和其他长期资产支付的现金182,757,927.7499,833,118.4299,539,838.25206,624,194.56
  投资支付的现金--0-
  质押贷款净增加额--0-
  取得子公司及其他营业单位支付的现金6,604,785.96-25,203,406.4225,203,347.02
  支付其他与投资活动有关的现金0-29,823,589.5965,171,073.18
  投资活动现金流出小计189,362,713.799,833,118.4354,566,834.26296,998,614.76
  投资活动产生的现金流量净额-25,830,853.69-86,098,566.52163,748,472.99-61,763,249
三、筹资活动产生的现金流量:
  吸收投资收到的现金0-238,713,461.4132,323,830
  其中:子公司吸收少数股东投资收到的现金0-238,713,461.4132,323,830
  取得借款收到的现金13,616,166,690.976,027,596,568.8824,752,970,472.5517,572,518,985.48
  收到其他与筹资活动有关的现金263,182,340.24200,276,681.06392,200,549.65362,070,243.53
  筹资活动现金流入小计13,879,349,031.216,227,873,249.9425,383,884,483.6117,966,913,059.01
  偿还债务支付的现金10,435,448,394.673,663,771,379.2124,114,209,320.9817,205,788,644.89
  分配股利、利润或偿付利息支付的现金487,499,540.63218,372,485.891,170,710,564.26903,337,673.06
  其中:子公司支付给少数股东的股利、利润74,401,741.927,188,840.32297,144,355.83180,691,927.14
  支付其他与筹资活动有关的现金445,096,552.33169,185,859.851,053,399,419.07526,162,335.86
  筹资活动现金流出小计11,368,044,487.634,051,329,724.9526,338,319,304.3118,635,288,653.81
  筹资活动产生的现金流量净额2,511,304,543.582,176,543,524.99-954,434,820.7-668,375,594.8
五、现金及现金等价物净增加额-1,123,955,640.58-1,225,729,954.95-36,016,258.33-3,060,404,005.2
  加:期初现金及现金等价物余额4,750,966,315.914,750,966,315.914,786,982,574.244,786,982,574.24
  期末现金及现金等价物余额3,627,010,675.333,525,236,360.964,750,966,315.911,726,578,569.04
补充资料:
  净利润312,530,169.22-521,328,438.97-
  资产减值准备5,223,536-909,318,679.07-
  固定资产和投资性房地产折旧111,259,818.05-239,347,525.35-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧111,259,818.05-239,347,525.35-
  无形资产摊销16,918,938.74-36,333,178.67-
  长期待摊费用摊销26,669,738.93-58,564,157.16-
  处置固定资产、无形资产和其他长期资产的损失-3,883,377.54--4,629,873.82-
  固定资产报废损失---189,424.35-
  公允价值变动损失43,645.49-3,068,104.51-
  财务费用323,158,126.58-758,261,522.73-
  投资损失-138,529,695.28--415,481,340.47-
  递延所得税-35,000,893.74--275,511,823.92-
  其中:递延所得税资产减少-38,790,793.86--308,971,250.41-
    递延所得税负债增加3,789,900.12-33,459,426.49-
  存货的减少67,616,892.79--149,151,116.18-
  经营性应收项目的减少-3,386,957,165.25--2,800,383,331.27-
  经营性应付项目的增加-1,683,659,481.69-1,673,291,496.93-
  其他694,366,822.78---
  现金的期末余额3,627,010,675.33-4,750,966,315.91-
  减:现金的期初余额4,750,966,315.91-4,786,982,574.24-
  现金及现金等价物的净增加额-1,123,955,640.58--36,016,258.33-
公告日期2026-08-262026-04-242026-04-242025-10-28
审计意见(境内)标准无保留意见
TOP↑